MEIRAGTX HOLDINGS PLC INDEMNIFICATION AGREEMENTIndemnification Agreement • May 29th, 2018 • MeiraGTx Holdings PLC • Biological products, (no disgnostic substances)
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into on ______________, 20[18] between MeiraGTx Holdings plc, a Cayman Islands exempted company (the “Company”), and [Name] (“Indemnitee”).
Employment AgreementEmployment Agreement • May 29th, 2018 • MeiraGTx Holdings PLC • Biological products, (no disgnostic substances) • New York
This Employment Agreement (“Agreement”) is entered into effective as of February 15th, 2016, by and between MeiraGTx LLC (“Meira”), a Delaware limited liability company, and its parent MeiraGTx Limited and subsidiaries (together, the “Company” or “MeiraGTx”), and Richard Giroux (“Employee”).
AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • May 29th, 2018 • MeiraGTx Holdings PLC • Biological products, (no disgnostic substances) • New York
This AGREEMENT AND PLAN OF MERGER (this “Agreement”) is entered into on this 31st day of December, 2015 (the “Effective Date”) by and between MeiraGTx Acquisition Corporation, a Delaware corporation (“Merger Sub”), BRI-Alzan Inc., a Delaware corporation (the “Company”), F-Prime Inc. (f/k/a Fidelity Biosciences Corp.), a Delaware corporation with the address of its principal office set forth on the signature page hereto (“Fidelity”), Gregory Petsko, an individual resident at the address set forth on the signature page hereto (“Petsko”), Dagmar Ringe, an individual resident at the address set forth on the signature page hereto (“Ringe”), and Brandeis University, a not-for-profit corporation duly incorporated and existing under the laws of the Commonwealth of Massachusetts with the address of its principal office set forth on the signature page hereto (“Brandeis” and together with Fidelity, Petsko and Ringe, each, a “Seller” and, collectively, the “Sellers”), Fidelity, solely in its capac
Confidential Treatment Requested by MeiraGTx Holdings plc LICENSE AGREEMENT between BRANDEIS UNIVERSITY and BRI-Alzan Inc.License Agreement • May 29th, 2018 • MeiraGTx Holdings PLC • Biological products, (no disgnostic substances) • Massachusetts
Confidential Portions of this Exhibit marked as [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission.
Service AgreementService Agreement • May 29th, 2018 • MeiraGTx Holdings PLC • Biological products, (no disgnostic substances)
